New Healthtech VC Funds in 2026

Masia is a Barcelona-based venture capital firm founded in 2025 by Carlos Trenchs and Pepe Borrell, investing in early-stage AI and frontier tech companies founded by people with a connection to Barcelona. The firm acts as an advisor rather than a lead investor or board member, relying on a network of more than 70 individual limited partners and more than 60 co-investing venture firms to support its portfolio.

True Beauty Ventures is a New York-based venture capital firm founded in 2020 by Rich Gersten and Cristina Nuñez, former colleagues at L Catterton and Tengram Capital Partners, investing in beauty, wellness, and personal care brands. The firm is majority female, and more than 80% of its portfolio companies have women or minority founders.

HIRAC Fund is a Tokyo-based venture capital fund operated by Money Forward Venture Partners, Inc., a wholly owned subsidiary of Japan's Money Forward. The fund invests in seed and early-stage startups using technology to address social problems and revitalize local economies, acting as a hub linking its financial-institution and corporate limited partners with portfolio companies for business partnerships and regional expansion.

Genesys Capital is a Toronto-based life sciences venture capital firm with more than 25 years of experience and over $400M invested across six early-stage venture funds, 44 companies, and 20 exits. Its Genesys University Seed Fund invests in early-stage life sciences spinouts from the University of Toronto, McMaster University, and their affiliated teaching hospitals, including Sunnybrook Health Sciences Centre and the University Health Network (UHN).

Phoenix Venture Partners is an Abu Dhabi-based venture capital firm investing in early-stage technology startups across the GCC, MENA, and G20 markets, with a focus on sectors including fintech, healthtech, and edtech.

Marin Sonoma Impact Ventures (MSIV) is a Corte Madera, California-based venture capital firm and the North Bay's first regional venture fund. Founded by Zachary Kushel in 2021, MSIV backs local entrepreneurs and startups in Marin and Sonoma counties as part of an “Invest Local” movement aimed at driving regional economic development and job creation.

Spark is a new €100 million venture capital fund from Bosch Ventures (Robert Bosch Venture Capital GmbH) dedicated to deep-tech startups across Germany. Set to begin investing on January 1, 2027, the fund sits alongside Bosch Ventures' existing global investment platforms and gives the firm a dedicated vehicle for backing early-stage German companies, with particular emphasis on the Baden-Wurttemberg region.

Forbion is a global life sciences venture capital firm headquartered in Naarden, the Netherlands, with additional offices in Munich and Boston. Founded two decades ago, the firm invests across the full lifecycle of biopharmaceutical innovation, backing therapeutics companies from company creation through late-stage growth. Forbion has financed 142 companies to date and manages roughly $8.4 billion in assets across 12 funds.

Graduate Ventures is a Netherlands-based venture capital firm founded in 2021 by alumni and entrepreneurs from Delft University of Technology and Erasmus University Rotterdam. The firm backs pre-seed and seed-stage startups and spin-outs founded by students, researchers, and alumni across Dutch universities, pairing capital with a network of more than 200 alumni investors who help portfolio companies grow.

Advent Life Sciences is a London-based venture capital firm founded in 2000 that invests in life sciences businesses across the UK, continental Europe, and the United States. The firm backs new drug discovery, enabling technologies, and medical technology companies from early-stage development through growth and commercialization, with additional offices in Paris and Boston.

Hatteras Venture Partners is a Durham, North Carolina–based venture capital firm founded in 2000 that invests in seed and early-stage companies in human medicine. The firm focuses on biopharmaceuticals, medical devices, and health technology, with a long-standing reputation for backing transformative healthcare innovations. Hatteras is a Registered Investment Adviser (RIA) and manages more than $900 million across seven venture funds.

Enable Ventures is a venture capital firm investing in AI-driven, disability-inclusive technology. Founded by disability rights attorney Regina Kline in partnership with Sorenson Impact Group, the firm positions disability-inclusive design as a performance and market-expansion advantage rather than a corporate social responsibility initiative.

Commonweal Ventures is a venture capital firm that invests in category-winning companies solving the country's toughest public-sector challenges. Founded by Nate Loewentheil, the firm backs founders building products where government functions as a customer, regulator, research partner, or market maker, drawing on an advisory network of former government officials, regulators, and industry operators.

Sofinnova Partners is a leading European venture capital firm specializing in life sciences, with a focus on healthcare and sustainability. Established in 1972 and headquartered in Paris, with additional offices in London and Milan, the firm has supported the growth of over 500 companies over its 50-year history.

Bramble Partners is a UK-based venture capital firm founded in 2024 by Henry Dimbleby, co-founder of the Leon restaurant chain and author of the UK government's National Food Strategy review, alongside co-founder Omar Habbal. The firm invests across the food value chain, aiming to build a food system that generates commercial returns while improving health outcomes and reducing environmental impact.

Lavni Ventures is an India-based venture capital firm and SEBI-registered Category II Alternative Investment Fund, founded in 2020. The firm invests in Indian deep-tech founders building foundational technologies in health and climate, with a thesis centered on capital-efficient, globally scalable science and engineering-driven solutions.

Amplify Capital is a Toronto-based venture capital firm investing in early-stage impact startups across climate, health and work technology. Founded in 2016 as the MaRS Catalyst Fund, the firm spun out of MaRS Discovery District in 2019 and is celebrating its tenth anniversary.

Brighteye Ventures is a European venture capital firm founded in 2017, investing in early-stage companies building what it calls HumanOS, technology that helps people learn, work, and adapt in the AI era. Since inception the firm has backed more than 50 companies and manages $245 million in assets under management across three funds.

Transformation Capital is a Boston- and San Francisco-based venture and growth equity firm founded in 2016, dedicated exclusively to digital health. The firm describes itself as the largest dedicated digital health venture and growth equity investor, with more than $2.5 billion in assets under management across four funds. Its portfolio spans 50+ companies, including Datavant, Sword Health, Grow Therapy, and SmarterDx.

Wittington Ventures is a Toronto-based venture capital firm founded in 2019 by the Weston family's holding company, Wittington Investments, investing in technology-oriented startups across Canada and the US with support from affiliated Canadian retail brands including Loblaw, Shoppers Drug Mart, Choice Properties, and Holt Renfrew.

W Health Ventures (also operating under its venture-studio brand 2070 Health) is a healthcare company-creation fund founded in 2020, with offices in Boston, Mumbai, Bengaluru, and Delhi. Rather than investing in existing startups, the firm builds healthcare companies from the ground up to address structural gaps in the India and US-India healthcare corridor.

Cherubic Ventures is a global seed-stage venture capital firm founded in 2014 by Matt Cheng, operating from Silicon Valley, Taipei, Shanghai, and Tokyo. The firm has built a network of more than 200 portfolio companies and 500+ founders, advisors, and institutional investors, and was among the first venture firms to adopt a solo GP model.

Ventures Platform is a Nigeria-based, pan-African venture capital firm investing in founders solving for non-consumption, plugging infrastructural gaps, and democratizing prosperity across the continent. Founded by Kola Aina, who formalized his investment activity into the firm in 2016, Ventures Platform has backed more than 75 active portfolio companies across six-plus African countries, including Paystack, PiggyVest, SeamlessHR, and Remedial Health.

Capital F is a San Francisco-based, all-female-led venture capital firm investing in markets where women drive demand, spanning health, AI, and digital commerce. Founded by longtime operators Dawn Dobras and Margaret Coblentz, who have worked together for nearly three decades including at Charlotte Russe.

FGV Capital, formerly known as Fiat Ventures, is a San Francisco-based venture capital firm investing in early-stage fintech, healthtech, and AI companies from pre-seed through Series A. The firm was founded in 2018 as Fiat Growth, a fintech growth consultancy, before launching its venture arm, Fiat Ventures, in 2021; in August 2026 the two entities rebranded together under the unified FGV brand. FGV Capital pairs capital with a full-stack growth, finance, and talent platform built from working inside more than 325 companies, rather than competing on check size alone.

Reach Capital is an early-stage venture capital firm founded in 2015 and based in San Francisco, investing in founders building technology across learning, health, and work. Spun out of NewSchools Venture Fund, the firm has backed more than 180 companies including Replit, ClassDojo, Brilliant, and Coral Care, with notable exits including Nearpod, SchoolMint, Gradescope, and GPTZero. Reach closed its fifth flagship fund at $265 million in August 2026, bringing total assets under management toward $1 billion.

Floating Point is an early-stage venture capital firm based in New York and Boston, founded in 2021 by Eddie Segel and John Loser, former Bridgewater hedge fund investors who were later on the founding team of Oscar Health. The firm invests in complex, regulated parts of the real economy, healthcare, logistics, finance, insurance, energy, and defense, backing full-stack businesses that pair technology with real-world operations and physical assets. Its portfolio spans more than 40 companies that have collectively raised over $2 billion, including Ledgebrook, Altana, Setpoint, Mevo, and Ataraxis.

GD1 (Global From Day One) is an Auckland-based venture capital firm backing New Zealand technology companies from pre-seed through Series B and supporting them in scaling into global markets. The firm operates as a generalist fund with specialist partners across hardware, health, frontier technology, software, and financial infrastructure, and every member of its investment team has previously built, operated, or scaled a company.

Cross-Border Impact Ventures (CBIV) is a Toronto-based impact venture capital firm founded in 2021 by Managing Partners Annie Thériault and Donna Parr, investing in health technology companies that address large global markets in women's, children's, and adolescent health.

White Star Capital is a global multi-stage venture capital and technology investment firm founded in 2014 by Eric Martineau-Fortin and Jean-Francois Marcoux. The firm partners with founders building internationally ambitious technology companies, operating from hubs in New York, London, Montreal, Toronto, Paris, and Milan, with a growing presence in Berlin, the Middle East, and Asia. White Star has grown from a five-person team in 2014 to more than 50 people across eight offices, and has recorded 22 exits from a portfolio of over 100 companies.

Aleph is an early-stage venture capital firm based in Tel Aviv, founded in 2013 by Michael Eisenberg and Eden Shochat, partnering with Israeli entrepreneurs to build large, globally significant technology companies. The firm has grown to a partnership of four, Eisenberg, Shochat, Yael Elad, and Tomer Diari, managing $850 million under management prior to its newest fund.

Fresenius Ventures is the corporate venture capital (CVC) arm of Fresenius SE & Co. KGaA, a Bad Homburg, Germany-based global healthcare company. Launched in July 2026, the unit combines venture investing with Fresenius' medical, regulatory, and operational expertise, and connects portfolio companies to clinical, scientific, and academic networks.

ReefHaven Ventures is a San Diego-based early-stage venture firm founded by Garrett Smith, PhD, a UC San Diego Bioengineering alumnus and founder-operator who has built and exited healthcare companies to Johnson & Johnson, AbbVie, and Medtronic. The firm is embedded within the UC San Diego innovation ecosystem, working closely with the UCSD MedTech Accelerator, Jacobs School of Engineering, Schools of Medicine and Biological Sciences, and the Office of Innovation and Commercialization to source breakthrough companies before they are widely visible to the broader venture market.

Tau Ventures is a Palo Alto-based seed venture firm founded in 2019 by Amit Garg and Sanjay Rao, both former partners at Norwest Venture Partners with combined experience of over 50 years in Silicon Valley across Google, Samsung NEXT, Microsoft, and McKinsey. The firm invests in applied AI companies across digital health, enterprise software, and physical AI, and has backed 80+ companies across four funds with portfolio companies collectively raising over $6B in follow-on capital. The name Tau references the Greek letter equal to 2π, a nod to the founders' thesis that AI is a fundamental tool, not a trend.

AlleyCorp is a New York-based early-stage venture firm founded by Kevin Ryan, widely regarded as the "Godfather of NYC tech", who previously served as CEO of DoubleClick (acquired by Google for $3.1B) and co-founded MongoDB, Gilt, Business Insider, and Zola. Originally operating as a family office for three decades, AlleyCorp raised its first institutional fund of $250M in 2023 and has now closed Fund II at $335M, making it one of New York's most significant venture institutions. The firm has eight unicorns in its current portfolio across healthcare, deep tech, and enterprise software.

Evidenced is a Washington, D.C.-based early-stage venture firm co-founded in 2022 by Sean Glass and Bryan Sivak. The firm's central thesis is that healthcare regulation and policy, typically viewed as risk factors by most investors, actually create measurable market openings, and that startups correctly positioned at the moment a regulatory tailwind fires grow faster with less risk than those competing in open markets. Glass co-founded and scaled Advantia Health to roughly $100 million in revenue and previously founded Higher One, which went public in 2010. Sivak served as CTO at the U.S. Department of Health and Human Services and held roles at Kaiser Permanente Ventures and Centene.

Magnify Ventures is a Santa Monica, California-based early-stage venture firm co-founded by Joanna Drake and Julie Wroblewski, focused exclusively on the care economy, the $648 billion market spanning prenatal and maternal care, family mental health, aging and longevity, home care, and the healthcare, financial, and consumer systems that surround family life. The firm is also co-founder of RAISE Global, which connects emerging fund managers with institutional LPs, and the Care Summit, an annual gathering of founders, investors, and operators in the care economy space.

Vicus Ventures is a New York and San Francisco-based seed venture firm founded by brothers Raj Singh Sandhu and Sunny Singh Sandhu in 2024. The name comes from the Latin word for village, a nod to the founders' Punjabi roots and their belief that the best companies are built with a village of support. The fund was deliberately capped at $55M in homage to Punjab, known as "the land of five rivers."

InvestEco Capital is a Toronto-based venture capital firm and impact investor founded in 2002, focused exclusively on the sustainable food sector. The firm is one of the few funds globally that specializes in high-growth, health-focused, and sustainability-driven food companies across consumer packaged goods, AgTech, and food system infrastructure. Fund IV is InvestEco's largest raise to date and continues a 24-year track record of investing in companies that combine commercial growth with measurable health and sustainability impact.

Nucleo Ventures is a Cluj-Napoca, Romania-based early-stage venture fund launched in June 2026, operating as the rebranded successor to Fortech Ventures, the investment arm of Fortech, one of Romania's largest software development companies. The rebrand marks the fund's transition to full institutional independence, anchored by a new $37.5M fund developed in partnership with Romania's North-West Regional Development Agency. Through its predecessor vehicle, the team backed 18 tech startups with $6.6M invested, a reported 29% IRR, and a current portfolio fair value of $9.5M.

Star51 Capital is a New York-based Medtech venture investment platform founded by Adam Rosenwach and Tal Wenderow. The firm is structured as an ecosystem fund, combining strategic capital, operator networks, and a proprietary AI platform (StarVision™), to bridge the gap between Medtech innovation and acquisition. The fund invests at the convergence of Medtech and AI, with anchor support from Abbott and Mayo Clinic providing clinical validation, commercialization pathways, and domain expertise beyond capital.

Base10 Partners is a San Francisco-based venture capital firm founded in 2018 by Adeyemi Ajao and TJ Nahigian, and is one of the largest Black-led venture capital firms in the world. The firm has run with a consistent thesis since inception, originally branded "Applied AI for the Real Economy" before being repositioned as "Automation" when early LPs considered applied AI too niche. With $850M in fresh capital closed in June 2026, Base10's total AUM reached $2.6B. Alongside its investment activity, Base10 runs the Advancement Initiative, committing up to 50% of carried interest to support students from all backgrounds pursuing careers in technology. The initiative partners with CodePath, which was recently named Anthropic's flagship economic mobility partner for AI-native engineering education.

THENA Capital is a London-based early-stage MedTech venture fund founded by Dr. Pamela Walker Geddes, Esther Reynal de St Michel Richardot, and Tatum Getty. The firm is built on the thesis that UK MedTech produces world-class science and clinical innovation but systematically lacks the specialist, commercially-minded, transatlantically-connected capital needed to scale. Fund I closed at ~$57M USD (£45M) in June 2026, anchored by the British Business Bank's Enterprise Capital Funds programme, making THENA the first all-female GP-led ECF-backed fund. The LP base is over 50% female, composed of healthcare leaders, pharma executives, specialist investors, operators, and family offices.

Merantix Capital is a Berlin-based venture capital firm founded in 2016 by Dr. Rasmus Rothe and Adrian Locher. It operates as part of the wider Merantix group, Europe's largest AI community organisation, and combines a venture studio, a direct investment fund, and an extensive corporate and institutional LP network. The firm partners with founders from pre-idea through seed stage, with a thesis that AI's biggest winners will be companies embedding intelligence directly into critical industrial workflows, not primarily those building models. The ~$113M USD AI Fund, closed in June 2026, is Merantix Capital's largest fund to date, nearly three times the size of its 2020 ~$38M USD debut vehicle. It is one of the largest dedicated early-stage industrial AI funds raised in Germany in 2026, backed entirely by corporate and institutional LPs rather than government capital.

R1 Capital is a Columbus, Ohio-based venture firm that launched in June 2026 as a standalone entity spun out of Rev1 Ventures, one of the nation's top venture studios. The firm was originally the investment arm operating within Rev1 Ventures, and now operates with its own brand, funds, and investment strategy while continuing to work alongside Rev1's studio infrastructure.R1 focuses on backing founders in enterprise AI/software, deep tech, and life sciences who are solving complex, real-world problems in large but undercapitalized markets, with a particular emphasis on companies emerging from the Midwest. The team has invested together for over a decade across multiple fund cycles, with a combined portfolio history of more than 150 startups supported.

Genesia Ventures is a Tokyo-based seed and early-stage venture capital firm founded by Soichi Tajima, investing in innovative digital startups across Japan, Southeast Asia, and India. The name is a portmanteau of "genesis" and "Asia," reflecting the firm's commitment to creating new business opportunities across the region. Operating since 2017, the firm has grown from a Japan-only seed investor into a four-office regional platform with full-time teams in Tokyo, Jakarta, Ho Chi Minh City, and Bengaluru. With Fund IV, Genesia manages approximately $340 million in assets across four funds.

Lansdowne Partners is a London-based investment management firm founded in 1998, known for fundamental equity investing across long-only and hedge fund strategies. In May 2026, the firm launched its first dedicated venture capital fund, a significant strategic expansion into early-stage investing, backed by the firm's existing track record as an informal early funder of the UK innovation ecosystem over the past decade. The VC fund is built on a core conviction that UK intellectual property is systematically undervalued relative to international peers, and that a concentrated, institutionally-backed vehicle deploying substantial capital with disciplined strategic guidance can bridge the persistent gap between early-stage UK innovation and global commercial scale.

Plus Partners is a Barcelona-based pre-seed and seed stage venture capital fund launched in 2024 by Enrique Linares and Oriol Juncosa, respectively a unicorn founder and a veteran seed investor with over 75 startup investments to his name. The fund is managed through Purpose Capital, the regulated management entity approved by Spain's CNMV, and is co-capitalised by public institutional backers and a deliberately curated LP base of successful Spanish tech entrepreneurs who have already built and exited companies.

Bridgewest Ventures is the venture capital platform of Bridgewest Group, a multi-asset investment firm headquartered in Coral Gables, Florida, with more than 25 years of experience building and investing in growth companies across seven countries. Bridgewest Ventures focuses on early-stage deep technology companies originating from New Zealand and Australia, partnering with researchers, universities, and founders to turn local innovation into globally competitive companies. Unlike many venture firms that operate as passive investors, Bridgewest Ventures takes an active operational role, working closely with founders to de-risk technology, strengthen governance, expand commercial capability, and create pathways into global markets.

Meridian Ventures is an early-stage venture capital firm founded in 2023 by Devon Gethers and Karlton Haney, both Harvard Business School graduates from the deferred enrollment program. Originally launched as SectionX Capital, the firm was Utah's first native Black-owned seed-stage venture fund. Meridian backs founders who have deferred MBAs from top business schools, a thesis built on the belief that this cohort is systematically overlooked despite the capabilities MBA programs develop. The firm has made more than 60 investments across two funds.

Kalos Ventures is an early-stage venture capital firm focused on technology companies addressing critical infrastructure needs across workforce, care and education. Led by Managing Partner Ashley Bittner, the New York City-based firm invests with conviction, leading early-stage rounds in companies built by experienced founders with unique insight into the challenges and opportunities created by AI transformation and shifting U.S. demographics. Kalos' approach is grounded in long-term partnerships beyond capital, offering advisory on capital formation, ecosystem building and talent strategy to scale portfolio companies.

Mother Ventures is a venture capital firm investing in companies building a better future for moms, parents, and families. Founded by General Partner Allison Stern, it is the first VC fund focused purely on the mother as consumer, spanning women's and family health, consumer products, entertainment, and shopping. In the U.S., moms are responsible for 85% of household purchases and have $2.4 trillion in spending power, which forms the core investment thesis of the firm.

Founded in 2022, Wisdom Ventures is an early-stage venture capital firm dedicated to investing in compassionate innovation that enhances human potential, wellbeing, and emotional resilience. Based in San Francisco, the firm invests globally in compassion and wellness startups, leveraging a partner team with extensive networks and a proven track record as investors, experts, and leaders. The firm bridges Silicon Valley innovation with deep expertise in mindfulness and emotional intelligence, supporting founders committed to not only building valuable companies but also creating lasting positive impact.

Unconventional Ventures is a Copenhagen-based impact venture firm founded by Thea Messel and Nora Bavey, built to challenge structural bias in venture capital and demonstrate the economic value of backing underrepresented founders. The firm backs pre-seed and seed stage companies founded by women, people with immigrant backgrounds, and LGBTQ+ entrepreneurs across the Nordics and Europe. All-women founding teams have historically received 1–2% of VC funding; founders of color less than 0.5%, Unconventional Ventures was built to redirect capital toward this structurally underserved pool.

Oncology Ventures is an Austin, Texas-based venture capital firm focused exclusively on companies improving cancer care. The firm closed Fund II at $62 million and was founded by Ben Freeberg, a cancer survivor who built the fund around the conviction that the people closest to the problem should be the ones funding the solutions. Oncology Ventures is anchored by a group of leading cancer care institutions — including Texas Oncology, Moffitt Cancer Center, City of Hope, Atlantic Health System, Cardinal Health, and Fred Hutch — whose clinical networks, patient data access, and procurement relationships are directly available to portfolio companies.

Kurma Partners is a Paris-based healthcare venture capital firm founded in 2009 and affiliated with Eurazeo, one of Europe's largest listed investment groups. The firm manages over €1 billion in assets and has raised four successive healthcare funds, with BioFund IV closed at €215 million as its largest to date. Kurma focuses exclusively on European healthcare innovation, investing across therapeutic biotech, medical technology, and diagnostics, with a team of 25 professionals operating from Paris and Munich.

Newfund is a Paris-based venture capital firm that launched HEKA, a dedicated €60 million fund focused exclusively on braintech — the convergence of neuroscience, digital health, and artificial intelligence applied to the brain and mind. HEKA was announced in late 2024 and positions Newfund as one of the few European funds with a thesis built entirely around brain health innovation. The fund operates in partnership with the FondaMental Foundation, one of Europe's leading research networks in psychiatry and neuroscience.

Eka Ventures is a London-based impact venture capital firm founded in 2018 by Jon Coker, Camilla Dolan, and Andrew Richardson. The firm invests in early-stage UK companies building solutions in health and wellbeing, sustainability, and financial inclusion. With Fund II, Eka has become the largest early-stage impact VC in the UK.

Alumni Ventures is one of the most active early-stage venture capital firms in the United States, managing more than $1.5 billion in committed capital across 1,600+ portfolio companies and over 40 thematic funds. Its Women's Fund backs startups founded or led by women, built on the thesis that female founders are systematically underfunded relative to the returns they deliver: in 2024, women-founded companies received only 2.3% of global VC funding despite generating $0.78 in revenue per funding dollar compared to $0.31 for male founders.

Sonder Capital is a San Carlos, California-based venture capital firm co-founded in 2019 by Fred Moll, MD, and Jay Watkins to back early-stage medical device, diagnostic, and healthtech companies with transformational potential. The firm draws on its founders' decades of operating experience in medtech to identify teams building technologies capable of creating new care pathways, not merely improving existing ones.

Staircase Ventures is a Toronto-based seed-stage venture capital firm founded in 2023 by Janet Bannister, one of Canada's most recognized startup investors. The firm was built around a single premise: that by investing in the development of founders as people, not just their companies, you can meaningfully change the trajectory of those businesses. Two funds in, the firm has established itself as the most founder-development-focused VC in the Canadian ecosystem.

FIRSTPICK is a Vilnius-based first-check venture capital firm founded in 2022 by Dmitrij Sosunov and Andra Bagdonaitė, focused exclusively on backing Baltic founders at the earliest possible stage: inception and pre-seed. The firm operates on the conviction that the strongest founders in Estonia, Latvia, and Lithuania are consistently underpriced by investors who rely on conventional signals like FAANG employment history, Ivy League credentials, or previous exits, and that identifying them early, before external validation exists, is both a defensible strategy and a genuine service to the regional ecosystem.

Pegasus Tech Ventures is a global venture capital firm headquartered in Silicon Valley that specializes in managing corporate venture capital programs for major multinational corporations. Founded by Anis Uzzaman, the firm operates as both a direct investor and a CVC platform partner, backing high-growth technology companies while helping corporate limited partners access innovation globally. With over $2 billion in assets under management and investments in more than 290 startups worldwide, Pegasus combines traditional venture investing with strategic corporate collaboration.

FutureFirst Ventures is an early stage venture capital firm founded in 2026 and headquartered in Tel Aviv, Israel. The firm was established by experienced venture investors Hila Rom and Tammy Mahn, both former managing partners at established investment platforms. FutureFirst focuses on backing founders building vertical AI companies across core industrial and enterprise sectors, with an emphasis on operational depth and global scalability. The firm positions itself as a hands-on partner, providing strategic guidance and access to international corporate networks and venture investors across the U.S. and Europe.

Frist Cressey Ventures (FCV) is a Nashville, Tennessee-based healthcare venture capital firm founded in 2016 by former U.S. Senate Majority Leader Bill Frist, MD and his longtime business partner Bryan Cressey. The firm was built on a singular and mission-driven thesis: to transform healthcare and improve patient lives by backing founders using technology to reshape how care is delivered across the United States. Now in its tenth year, FCV has grown from an early-stage healthcare specialist into a near-billion-dollar platform with 44 investments, 14 successful exits, and a strategic LP base that touches more than 50 percent of the American population. The firm has been recognized by Time Magazine as one of the top US venture capital firms, and its first two funds rank in the top five percent of all venture capital funds for their respective vintages.

Santé Ventures is an Austin-based venture capital firm specializing in early-stage life sciences and healthcare investing. The firm has built a long-standing reputation for backing scientifically rigorous companies tackling complex clinical and healthcare challenges. Santé Ventures is known for its hands-on, company-building approach and for partnering closely with founders from early development through clinical and commercial inflection points.

Epidarex Capital is a transatlantic life science venture capital firm based in Edinburgh and Bethesda. Since inception, the firm has focused on building companies around breakthrough academic science from leading UK and US research hubs. Epidarex backs founders and researchers working on high impact healthcare innovations with the potential to address major unmet medical needs across oncology, cardiometabolic disease, autoimmune conditions, and neurological disorders.

Healthier Capital is a premier health-tech venture capital firm dedicated to driving transformative shifts in the healthcare landscape through technology-powered innovation. Based in Menlo Park, the firm was founded on the principle that superior health outcomes and significant value creation are inextricably linked. Healthier Capital distinguishes itself through a team of "been there, done that" operators who have led some of the most influential organizations in modern healthcare. The firm acts as a high-impact strategic partner, leveraging an unparalleled network across health systems, insurers, and policymakers to help early-stage companies navigate the complexities of clinical adoption and regulatory compliance.

Axiom Partners is a San Francisco-based early-stage venture capital firm founded by Sandhya Venkatachalam, a veteran of Khosla Ventures and Social Capital, dedicated to backing founders building practical AI applications that address what the firm calls the "capacity crunch": the global shortage of skilled professionals in healthcare, education, finance, and other essential sectors that AI can now help bridge. The firm's thesis is that AI makes it possible to democratize access to expertise that has historically been available only to the wealthy, and that the most important companies of the next decade will be those that use AI to serve 8 billion people, not just the privileged few.